TOP STORIES

• BUSINESS Nichi-Iko to Discontinue 221 Additional Products, Generic Peers Looking into Impact
  March 2, 2023

• BUSINESS Nichi-Iko Exits North American Market, Biosimilar Biz with Sagent Sell-Off
  March 1, 2023

• BUSINESS Japan Approves Pfizer’s Omicron-Tailored Vaccine for Ages 5-11
  March 1, 2023

• REGULATORY Japan Panel Backs Approval of 1st Nasal Flu Vaccine
  February 28, 2023

• REGULATORY Pfizer’s Omicron-Adapted Jab for Ages 5-11 in Line for Japan Approval
  February 28, 2023

• REGULATORY Nipro Pharma Told to Improve Biz over Violations Spanning 42 Products, Faked Records
  February 27, 2023

• REGULATORY Japan Approves Precedex for Pediatric Use, Expands Labels for Nubeqa, Rinvoq, and More
  February 27, 2023

• REGULATORY Nipro Pharma Likely to Face Business Improvement Order over Violations
  February 24, 2023

• BUSINESS Kidswell Bio Revs Up Biosimilar Push, G-Lasta, Eylea Follow-Ons in Development
  February 22, 2023

• ORGANIZATION Policy Veterans’ Group Floats Proposal to Prevent Unprofitability to Stabilize Drug Supply
  February 21, 2023

• BUSINESS Shareholders OK Nichi-Iko’s Delisting, Turnaround under New Management; President to Exit March 8
  February 20, 2023

• BUSINESS ViiV Eyes More Uptake for Japan’s 1st Long-Acting HIV Med, Revs Up Development Drive
  February 17, 2023

• REGULATORY Chuikyo OKs Pricing Plan for Xocova Listing, 100 Billion Yen Threshold for Possible Re-Pricing
  February 16, 2023

• REGULATORY Expert Panel Agrees on Need for Generic Industry Shakeup, Company Criteria Floated
  February 16, 2023

• BUSINESS As Global Race Heats Up for RAS Drugs, Japan Players Joining Fray with New Modalities
  February 15, 2023

• BUSINESS BMS Mulls CAR-T Manufacturing in Japan, Definitive Plans Expected by Year-End
  February 14, 2023

• BUSINESS Asahi Kasei to Push Teribone Auto-Injector, but AG Remains an Option: President
  February 13, 2023

• REGULATORY Japan Cancels 140 Million-Plus Dose Order of Novavax’s COVID Vaccine
  February 13, 2023

• REGULATORY Expert Panel’s Proposal Likely to Involve “2-Stage” Reform, Touch on Funding Too: Chairman
  February 10, 2023

• BUSINESS Kyowa Kirin Has No Plans to Launch Biosame of G-Lasta: President
  February 10, 2023

ページ

• « 先頭
• ‹ Prev
• …
• 58
• 59
• 60
• 61
• 62
• 63
• 64
• 65
• 66
• …
• Next ›
• 最終 »